Sort   by:  
 Page size 
UnknownInfluence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States.

Background

The reported prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD) is 32%. We assessed the influence of NAFLD on IBD hospitalizations in the United States (US).

Methods

We utilized the National Inpatient Sample database, fr...
S-EPMC10662065 | biostudies-literature
UnknownEffectiveness of upadacitinib in ulcerative colitis patients with prior tofacitinib exposure: a systematic review and meta-analysis.

Background

Upadacitinib, a selective Janus kinase (JAK) inhibitor, is a recently approved therapy for moderate-to-severe ulcerative colitis (UC). Limited data are available on its efficacy in patients previously exposed to tofacitinib, a non-selective JAK inhibitor. Therefore, we conducted a...
S-EPMC12421357 | biostudies-literature
UnknownComparing adalimumab and infliximab in the prevention of postoperative recurrence of Crohn's disease: a systematic review and meta-analysis.

Background

Crohn's disease is a relapsing disease that often requires operative management. Prevention of postoperative recurrence (POR) is critical to maintain remissions. Biologic agents have proven to be most successful in remission maintenance. We made a direct head-to-head comparison of...
S-EPMC10152807 | biostudies-literature
Sort   by:  
 Page size